SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001069530-19-000019
Filing Date
2019-03-29
Accepted
2019-03-28 19:04:31
Documents
55
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sava-20181231x10k.htm 10-K 1948742
2 EX-3.3 sava-20181231xex3_3.htm EX-3.3 14978
3 EX-3.4 sava-20181231xex3_4.htm EX-3.4 269565
4 EX-23.1 sava-20181231xex23_1.htm EX-23.1 8915
5 EX-31.1 sava-20181231xex31_1.htm EX-31.1 21253
6 EX-31.2 sava-20181231xex31_2.htm EX-31.2 21598
7 EX-32.1 sava-20181231xex32_1.htm EX-32.1 11757
  Complete submission text file 0001069530-19-000019.txt   5386848

Data Files

Seq Description Document Type Size
8 EX-101.INS sava-20181231.xml EX-101.INS 920328
9 EX-101.SCH sava-20181231.xsd EX-101.SCH 28268
10 EX-101.CAL sava-20181231_cal.xml EX-101.CAL 26522
11 EX-101.DEF sava-20181231_def.xml EX-101.DEF 86101
12 EX-101.LAB sava-20181231_lab.xml EX-101.LAB 254450
13 EX-101.PRE sava-20181231_pre.xml EX-101.PRE 208917
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29959 | Film No.: 19713428
SIC: 2834 Pharmaceutical Preparations